investorscraft@gmail.com

Intrinsic Value of Ayala Pharmaceuticals, Inc. (ADXS)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-10-31 and quarterly data as of 2023-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-92.3NaN
Revenue, $0NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m20NaN
Operating income, $m-19NaN
EBITDA, $m-19NaN
Interest expense (income), $mNaN
Earnings before tax, $m-15NaN
Tax expense, $m0NaN
Net income, $m-15NaN

BALANCE SHEET

Cash and short-term investments, $m25NaN
Total assets, $m26NaN
Adjusted assets (=assets-cash), $m1NaN
Average production assets, $m2NaN
Working capital, $m23NaN
Total debt, $m0NaN
Total liabilities, $m2NaN
Total equity, $m24NaN
Debt-to-equity ratio0.001NaN
Adjusted equity ratio-2.173NaN

CASH FLOW

Net income, $m-15NaN
Depreciation, amort., depletion, $m0NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-15NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m0NaN
Free cash flow, $m-15NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m23
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount